|  |  | MSC-SAR vs MSC-CTRL P03 | MSC-SAR vs MSC-CTRL P10 | U2OS vs MSC-CTRL P03 | |||
---|---|---|---|---|---|---|---|---|
GENE SYMBOL | Refseq | Description | Fold Regulation | T-TEST p value | Fold Regulation | T-TEST p value | Fold Regulation | T-TEST p value |
ANGPT2 | NM_001147 | Angiopoietin 2 | 3,60 | 0,017031 | 3,54 | 0,001587 | 2,01 | 0,123058 |
BRCA1 | NM_007294 | Breast cancer 1, early onset | 1,56 | 0,184634 | 2,59 | 0,005080 | 13,19 | 0,000088 |
CDC25A | NM_001789 | Cell division cycle 25 homolog A (S. pombe) | 2,01 | 0,030181 | 2,44 | 0,011524 | 15,56 | 0,000083 |
CFLAR | NM_003879 | CASP8 and FADD-like apoptosis regulator | -3,43 | 0,013343 | -1,91 | 0,017928 | -1,42 | 0,115505 |
CHEK2 | NM_007194 | CHK2 checkpoint homolog (S. pombe) | 1,03 | 0,930306 | 1,23 | 0,735103 | 7,49 | 0,000340 |
COL18A1 | NM_030582 | Collagen, type XVIII, alpha 1 | -2,85 | 0,034861 | -1,14 | 0,967097 | 2,94 | 0,018415 |
E2F1 | NM_005225 | E2F transcription factor 1 | 1,69 | 0,152813 | 2,64 | 0,036988 | 18,50 | 0,000019 |
GZMA | NM_006144 | Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | 4,14 | 0,064832 | 3,86 | 0,021397 | 2,28 | 0,018937 |
IFNA1 | NM_024013 | Interferon, alpha 1 | 2,15 | 0,231676 | 4,32 | 0,000719 | -4,17 | 0,208829 |
IGF1 | NM_000618 | Insulin-like growth factor 1 (somatomedin C) | 3,98 | 0,023798 | 5,26 | 0,003415 | 1,41 | 0,704213 |
MMP9 | NM_004994 | Matrix metallopeptidase 9 (gelatinase B, 92Â kDa gelatinase, 92Â kDa type IV collagenase) | 4,05 | 0,033049 | 2,76 | 0,957572 | 152,53 | 0,000000 |
PDGFB | NM_002608 | Platelet-derived growth factor beta polypeptide | 2,41 | 0,057864 | 2,80 | 0,027891 | 174,40 | 0,000107 |
SERPINB5 | NM_002639 | Serpin peptidase inhibitor, clade B (ovalbumin), member 5 | 4,32 | 0,056954 | 3,54 | 0,010117 | 4,04 | 0,000712 |
TNF | NM_000594 | Tumor necrosis factor | 4,04 | 0,030749 | 2,77 | 0,010705 | 1,54 | 0,285973 |
VEGFA | NM_003376 | Vascular endothelial growth factor A | -1,97 | 0,006089 | -6,84 | 0,008108 | -12,44 | 0,000009 |